Charles River Laboratories International operates in the healthcare sector, providing regulated research services and ...
The FDA has published new guidance aimed at reducing or stopping toxicity studies of monoclonal antibody-based drugs in non-human primates (NHPs), in the latest stage of an ongoing effort to reduce ...
This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback